CMPX
NASDAQ · Biotechnology

Compass Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$2.06
+0.07 (+3.52%)
As of Aug 8, 1:42 AM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +2,510.2% upside
Low Target $36.32
Average Target $53.77
High Target $66.75
Current Price $2.06
Current
$2.06
Target
$53.77
$36.32 $53.77 avg $66.75
Scenario Analysis
Bear Case
$36.32
1,663.1%
Low target
Base Case
$53.77
+2,510.2%
Avg target
Bull Case
$66.75
+3,140.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.88
-70.1% from high
52-Week Low
$1.61
+28.0% from low
Target vs 52W High
$53.77
+681.5% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.11
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%